A Randomized, Single Blind Study to Investigate the Tolerability and Effects on Epidermal Nerve Fiber Density of Multiple Low-Concentrations of Capsaicin Topical Liquid NGX-1998 in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 08 May 2012
At a glance
- Drugs Capsaicin (Primary)
- Indications Pain
- Focus Adverse reactions
- 16 Jul 2008 New trial record.
- 11 Jul 2008 Dosing initiated in phase I trial according to NeurogesX media release.